The global cartilage degeneration market is witnessing steady growth, driven by the increasing prevalence of joint-related disorders and advancements in regenerative therapies. Valued at US$ 11.6 billion in 2023, the market is projected to reach US$ 24.9 billion by 2034, expanding at a CAGR of 7.1% from 2024 to 2034. The rising burden of osteoarthritis, coupled with growing sports injuries and...